<scp>MRD</scp> ‐negative conversion with daratumumab monotherapy in newly diagnosed multiple myeloma patients in ≥ <scp>VGPR</scp> / <scp>MRD</scp> ‐positive after first‐line therapy: Final analysis of the open‐label, single‐arm multicentric phase 2 trial <scp>DART4MM</scp>

Alessandro Gozzetti, Paola Pacelli, Federico Caroni, Donatella Raspadori, Elena Bestoso, Elisabetta Antonioli, Gabriele Buda, Sara Ciofini, Adele Santoni, Luca Puccetti, Francesca Bacchiarri, Ludovica Pengue, Dania Tocci, Irene Attucci, Maria Livia del Giudice, Miriana Ruggieri, Alessandra Lombardo, Anna Marina Liberati, Veronica Candi, Vincenzo Sammartano, Alessandra Cartocci, Anna Sicuranza, Sara Galimberti, Alessandro Maria Vannucchi, Monica Bocchia

Open source

DOI: 10.1111/bjh.70448
Published: 2026-03-26
Container: British Journal of Haematology
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/bjh.70448,
  title = {<scp>MRD</scp>
                    ‐negative conversion with daratumumab monotherapy in newly diagnosed multiple myeloma patients in ≥
                    <scp>VGPR</scp>
                    /
                    <scp>MRD</scp>
                    ‐positive after first‐line therapy: Final analysis of the open‐label, single‐arm multicentric phase 2 trial
                    <scp>DART4MM</scp>},
  author = {Alessandro Gozzetti and Paola Pacelli and Federico Caroni and Donatella Raspadori and Elena Bestoso and Elisabetta Antonioli and Gabriele Buda and Sara Ciofini and Adele Santoni and Luca Puccetti and Francesca Bacchiarri and Ludovica Pengue and Dania Tocci and Irene Attucci and Maria Livia del Giudice and Miriana Ruggieri and Alessandra Lombardo and Anna Marina Liberati and Veronica Candi and Vincenzo Sammartano and Alessandra Cartocci and Anna Sicuranza and Sara Galimberti and Alessandro Maria Vannucchi and Monica Bocchia},
  year = {2026},
  journal = {British Journal of Haematology},
  doi = {10.1111/bjh.70448},
  url = {https://doi.org/10.1111/bjh.70448}
}

RIS

TY  - JOUR
TI  - <scp>MRD</scp>
                    ‐negative conversion with daratumumab monotherapy in newly diagnosed multiple myeloma patients in ≥
                    <scp>VGPR</scp>
                    /
                    <scp>MRD</scp>
                    ‐positive after first‐line therapy: Final analysis of the open‐label, single‐arm multicentric phase 2 trial
                    <scp>DART4MM</scp>
AU  - Alessandro Gozzetti
AU  - Paola Pacelli
AU  - Federico Caroni
AU  - Donatella Raspadori
AU  - Elena Bestoso
AU  - Elisabetta Antonioli
AU  - Gabriele Buda
AU  - Sara Ciofini
AU  - Adele Santoni
AU  - Luca Puccetti
AU  - Francesca Bacchiarri
AU  - Ludovica Pengue
AU  - Dania Tocci
AU  - Irene Attucci
AU  - Maria Livia del Giudice
AU  - Miriana Ruggieri
AU  - Alessandra Lombardo
AU  - Anna Marina Liberati
AU  - Veronica Candi
AU  - Vincenzo Sammartano
AU  - Alessandra Cartocci
AU  - Anna Sicuranza
AU  - Sara Galimberti
AU  - Alessandro Maria Vannucchi
AU  - Monica Bocchia
PY  - 2026
JO  - British Journal of Haematology
DO  - 10.1111/bjh.70448
UR  - https://doi.org/10.1111/bjh.70448
ER  -

APA

Gozzetti, A., Pacelli, P., Caroni, F., Raspadori, D., Bestoso, E., Antonioli, E., Buda, G., Ciofini, S., Santoni, A., Puccetti, L., Bacchiarri, F., Pengue, L., Tocci, D., Attucci, I., Giudice, M. L. D., Ruggieri, M., Lombardo, A., Liberati, A. M., Candi, V., Sammartano, V., Cartocci, A., Sicuranza, A., Galimberti, S., Vannucchi, A. M., & Bocchia, M. (2026). <scp>MRD</scp> ‐negative conversion with daratumumab monotherapy in newly diagnosed multiple myeloma patients in ≥ <scp>VGPR</scp> / <scp>MRD</scp> ‐positive after first‐line therapy: Final analysis of the open‐label, single‐arm multicentric phase 2 trial <scp>DART4MM</scp>. British Journal of Haematology. https://doi.org/10.1111/bjh.70448

Source records

crossref · retrieved 2026-09-25T07:32:39.614Z